This filing reports initial beneficial ownership of securities by Daniel Jude Pollock, a director at Immuron Ltd. The report details holdings of ordinary shares and options to acquire ordinary shares. Pollock directly holds 568,750 ordinary shares and indirectly holds 174,480 ordinary shares through joint ownership wit...

This filing details the beneficial ownership of Immuron Ltd (IMRN) by its Chief Commercial Officer, Flavio Palumbo. As of March 18, 2026, Mr. Palumbo directly owns 1,142,909 ordinary shares. Additionally, he holds 640,824 performance rights, which are exercisable at any time before their expiration on June 30, 2029. Th...

This filing documents a Power of Attorney granted by Penny Renee Fleck, Chief Development Officer of MeiraGTx Holdings plc, to Richard Giroux, Alexandria Forbes, Ph.D., and Robert J. Wollin. The purpose of this Power of Attorney is to authorize these individuals to act on Ms. Fleck's behalf in executing and filing Form...

This filing details Oramed Pharmaceuticals Inc.'s beneficial ownership of Lifeward Ltd. ordinary shares. The ownership is subject to various limitations based on the type of security and exercise terms. Specifically, pre-funded warrants are limited to 49.99% beneficial ownership, share purchase warrants are also limite...